Bioprospecting - Why is it so unrewarding?

Biodiversity and Conservation

Volumn 12, Issue 2, 2003, Pages 207-216

  Firn, Richard D ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Bioprospecting; Conservation; Screening; Secondary metabolism

Indexed keywords

BIODIVERSITY; CHEMICAL INDUSTRY; CONSERVATION; PHARMACEUTICAL INDUSTRY; RESOURCE MANAGEMENT; SECONDARY METABOLITE;

EID: 0037316366     PISSN: 09603115     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021928209813     Document Type: Article

References (29)

1. Aylward B.A. 1995. The role of plant screening and plant supply in biodiversity conservation, drug development and health care. In: Swanson T. (ed.), Intellectual Property Rights and Biodiversity Conservation. Cambridge University Press, Cambridge, UK, pp. 93-126.
2. Balick M.J. and Mendelsohn R. 1992. Assessing the economic value of traditional medicines from tropical rain forests. Conservation Biology 6: 128-130.
3. Barbier E.B. and Aylward B.A. 1996. Capturing the pharmaceutical value of biodiversity in a developing country. Environmental & Resource Economics 8: 157-181.
4. Chadwick D.J. and Whelan J. 1992. Secondary Metabolites: Their Function and Evolution. John Wiley, Chichester, UK.
5. Cordell G.A. 2000. Biodiversity and drug discovery - a symbiotic relationship. Phytochemistry 55: 463-480.
6. Demain A.L. 1995. Why do microorganisms produce antimicrobials? In: Hunter P.A., Darby G.K. and Russell N.J. (eds), 50 Years of Antimicrobials. Society for General Microbiology Symposium Vol. 53. Cambridge University Press, Cambridge, UK, pp. 205-228.
7. Dhillion S.S. and Amundsen C. 2000. Bioprospecting and the maintenance of biodiversity. In: Svarstad H. and Dhillion S.S. (eds), Responding to Bioprospecting - from Biodiversity in the South to Medicines in the North. Spartacus Forlag, Oslo, Norway, pp. 103-132.
8. Eisner T. 1989. Prospecting for nature's chemical riches. Issues in Science and Technology 6: 31-34.
9. Fellows L. and Scofield A. 1995. Chemical diversity in plants. In: Swanson T. (ed.), Intellectual Property Rights and Biodiversity Conservation. Cambridge University Press, Cambridge, UK, pp. 19-44.
10. Firn R.D. and Jones C.G. 1995. An explanation of secondary product 'redundancy'. In: Romeo J.T., Saunders J.A. and Barbosa P. (eds), Phytochemical Diversity and Redundancy in Ecological Interactions. Plenum Press, New York, pp. 295-312.
11. Firn R.D. and Jones C.G. 1998. Avenues of discovery in bioprospecting. Nature 393: 617.
12. Firn R.D. and Jones C.G. 2000. The evolution of secondary metabolism - a unifying model. Molecular Microbiology 37: 989-994.
13. Fraenkel G.S. 1959. The raison d'être of secondary plant substances. Science 129: 1466-1470.
14. Garrity G.M. and Hunter-Cevera J. 1999. Bioprospecting in the developing world. Current Opinion in Microbiology 2: 236-240.
15. Handelsman J., Rondon M.R., Brady S.F., Clardy J. and Goodman R.M. 1998. Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products. Chemistry and Biology 5: 245-249.
16. Jones C.G. and Firn R.D. 1991. On the evolution of secondary plant chemical diversity. Philosophical Transactions of the Royal Society of London, Series B 333: 273-280.
17. Macilwain C. 1998. When rhetoric hits reality in debate on bioprospecting. Nature 392: 535-540.
18. Nisbet L.J. 1992. Useful functions of microbial natural products. In: Chadwick D.J. and Whelan J. (eds), Secondary Metabolites: Their Function and Evolution. John Wiley, Chichester, UK, p. 299.
19. Pearce D.W. and Puroshothamon S. 1995. The economic value of plant-based pharmaceuticals. In: Swanson T. (ed.), Intellectual Property Rights and Biodiversity Conservation. Cambridge University Press, Cambridge, UK, pp. 127-138.
20. Principe P. 1996. Monetizing the pharmacological benefits of plants. In: Balick M.J., Elisabetsky E. and Laird S.A. (eds), Medicinal Resources of the Tropical Forest: Biodiversity and its Importance to Human Health. Columbia University Press, New York.
21. Rausser G.C. and Small A.A. 2000. Valuing research leads: bioprospecting and the conservation of genetic resources. Journal of Political Economy 108: 173-206.
22. Reid W.V., Laird S.A., Gamez R., Sittenfeld A., Janzen D.H., Gollin M. et al. 1993. A new lease on life. In: Biodiversity Prospecting: Using Genetic Resources for Sustainable Development. World Resources Institute, Washington, DC, pp. 1-52.
23. Sheldon J.W. and Balick M.J. 1995. Ethnobotany and the search for balance between use and conservation. In: Swanson T. (ed.), Intellectual Property Rights and Biodiversity Conservation. Cambridge University Press, Cambridge, UK, pp. 45-64.
24. Simpson R.D., Sedjo D., Roger A. and Reid J.W. 1996. Valuing biodiversity for use in pharmaceutical research. Journal of Political Economy 104: 163-185.
25. Simpson R.D. 1997. Biodiversity Prospecting: Shopping the Wilds is not the Key to Conservation. RFF Resources 126 (http://www.rff.org/resources-articles/files/biodprospect.htm).
26. Svarstad H. and Dhillion S.S. 2000. Responding to Bioprospecting - from Biodiversity in the South to Medicines in the North. Spartacus Forlag, Oslo, Norway.
27. Swanson T. 1995. The appropriation of evolution's values: an institutional analysis of intellectual property regimes and biodiversity conservation. In: Swanson T. (ed.), Intellectual Property Rights and Biodiversity Conservation. Cambridge University Press, Cambridge, UK, pp. 141-175.
28. ten Kate K. and Laird S.A. 1999. The Commercial uses of Biodiversity. Access to Genetic Resources and Benefit Sharing. Earthscan, London, p. 416.
29. Wells W.A. 1998. Digging the dirt. Chemistry and Biology 5: 15-16.